Semax and the ACTH(4-10) derivatives
Semax is a heptapeptide derived from ACTH(4-10), modified so that it retains neurotropic activity without the corticotropic effects of the parent hormone. The published research concentrates on BDNF and NGF expression in the hippocampus, on dopaminergic and serotonergic modulation, and on neuroprotection in ischemic models — it has been studied in stroke settings in Russian clinical work. What makes it interesting as a research compound is the speed of the reported BDNF response, which appears in the literature within hours rather than days.



